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Objective: Each year 45 million surgical procedures are performed in the 
United States, and a significant number of these are performed on hypothy-
roid patients. Little guidance is available to determine the postoperative risk 
to these subjects. We hypothesized that new surgical techniques and modern 
anesthesia would lead to no differences in outcome between hypothyroid pa-
tients and euthyroid controls. Methods: We queried surgical databases in our 
health system for patients who underwent an operative procedure between 
January 1, 2010 and December 31, 2015 with a TSH > 10 mcU/mL or a FT4 < 
0.6 ng/dL. Identified patients were matched to euthyroid controls selected for 
age, sex, surgical procedure, and search interval. Predicted length of hospital 
stay (LOS) was determined using the American College of Surgeons National 
Surgical Quality Improvement Program surgical risk calculator. Results: We 
identified 29 hypothyroid patients. The LOS was significantly longer for the 
hypothyroid patients compared to the predicted LOS (14.4 vs 6.7 days, P < 
0.001). The LOS in the matched controls was not significantly different than 
their predicted LOS (9.6 vs 7.1 days, P = 0.11). Other complications were not 
different between the hypothyroid and control patients. Conclusions: In 
contrast to our initial hypothesis, hypothyroidism is associated with a 2-fold 
longer LOS following surgery. Hypothyroidism continues to place patients at 
increased surgical risk. 
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for patients not requiring emergent surgery. Despite the extra care, evidence that 
this activity improves outcomes is controversial. Some evidence indicates that 
preoperative evaluation is beneficial [1] [2] [3], but at least one study suggests 
that these evaluations may prolong hospital stay and increase mortality [1]. We 
are unaware of any study that suggests a benefit to screening for hypothyroidism 
in the preoperative evaluation. 
One of the most widely used measures to predict hospital stay length and 
mortality is the Elixhauser Comorbidity Index [4]. This study found that hypo-
thyroidism was associated with a 7% increase in hospital stay and, surprisingly, a 
30% decrease in in-hospital mortality. The decrease in hospital mortality is in 
contrast to other studies that document increased hospital mortality with hypo-
thyroidism [5] [6] [7]. Given the effects the thyroid has on the cardiovascular, 
respiratory, and gastrointestinal systems, it is intuitive that hypothyroidism 
might contribute to greater perioperative morbidity, as suggested by a recent re-
view [8]. However, if greater morbidity occurs, the extent of its clinical signific-
ance has not been clearly demonstrated. This is especially important since can-
celling a scheduled surgery until a patient is euthyroid may impose significant 
inconvenience to the patient and cost to the health-care system, as it usually 
means a delay of surgery for a minimum of six to eight weeks. These competing 
issues often make it difficult to accurately weigh the risks versus benefits of ei-
ther proceeding with or cancelling surgery, posing a significant clinical dilemma 
to the physician performing the preoperative examination. 
Investigations aimed at addressing the dilemma of whether to operate or delay 
the operation have previously shown conflicting results. A retrospective study 
conducted in 1983 that compared 59 hypothyroid patients to 59 matched con-
trols showed no difference between controls and patients with mild to moderate 
hypothyroidism (TSH > 15 μU/mL or T4 < 4 μg/dL) to warrant a delay of sur-
gery [9]. A second study conducted the following year, comparing 40 hypothy-
roid patients (T4 1.9 ± 1.0 μg/dL) to 80 controls, showed an increased risk of 
intraoperative hypotension; heart failure in patients undergoing cardiac surgery; 
GI and neuropsychiatric complications; and an inability to mount a fever in the 
setting of infection [10]. Certainly, the most feared and potentially serious com-
plication of performing surgery on a hypothyroid patient is the risk of precipi-
tating myxedema coma, which, although rare, is an extreme form of hypothy-
roidism that can quickly escalate to death [11]. There has been at least one case 
report of a similar circumstance in which a 78-year-old hypothyroid man with a 
preoperative TSH of 25 one week prior to surgery underwent a cardiac operation 
that resulted in myxedema coma and life-threatening cardiac depression; on 
postoperative day 3, thyroid function tests showed a TSH of 13 [12]. 
Given the scarcity and inconsistency of data we felt further scrutiny of this 
topic was needed. Furthermore, because of the advances in anesthesia and sur-
gical approaches over the last three decades, we hypothesized that length of stay 
would not be significantly affected in patients with mild hypothyroidism. Thus, 
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we performed an up-to-date retrospective, observational study to better under-
stand modern-day perioperative risks of hypothyroid patients, comparing the 
primary outcomes of length of stay, mortality, and ischemic cardiac events. Sec-
ondary outcomes included the presence or absence of fever in the setting of 
post-operative infection, hypothermia, hypotension, prolonged anesthetic re-
covery time/time to extubation, ileus, altered mentation/delirium, hyponatremia, 
and bradycardia. 
2. Materials and Methods 
2.1. Study Design and Case Selection 
This study was approved by the Indiana University Institutional Review Board 
with the specific aim of comparing length of hospital stay between hypothyroid 
patients and controls. We searched Indiana University Health’s electronic med-
ical records (EMR) for patients who had undergone a surgical procedure and 
had a TSH above the upper limit of normal or a free T4 of <0.6 ng/dL between 
January 1, 2010 and December 31, 2015. We obtained 788 charts to review. To 
be included in the study, patients had to be 18 years of age or older with either 
an elevated TSH or a low FT4 within four weeks of a major surgical procedure at 
one of our campus sites. If the FT4 was <0.6 the subject also had to have an ele-
vated TSH. TSH values in our study cohort ranged from 7.18 to 84.736 mcU/mL 
with an average of 29.19 mcU/mL (standard deviation 20.54 mcU/mL). Of the 
788 screened, 29 cases satisfied our study criteria after excluding those due to 
patient duplication, ineligible procedures, thyroid function tests more than four 
weeks from surgery, and incorrect or absent thyroid function tests. Power analy-
sis based on a predicted mean hospital stay of 7 ± 3 days and a 50% increase in 
predicted hospital stay when hypothyroid required 24 subjects at 80% power (12 
subjects in each group). We also obtained a set of local euthyroid control sub-
jects by searching the EMR for patients who had undergone similar surgical 
procedures during the same time interval and matched for age ±5 years and sex. 
This yielded approximately 15 potential controls for each hypothyroid subject. 
From the list of potential controls we randomly chose a control and reviewed 
that control’s chart to assure they met inclusion and exclusion criteria criteria 
and did not differ in other confounding variables. Only that control was used for 
subsequent analysis. Table 1 presents the characteristics of the subjects and Ta-
ble 2 gives the surgical procedures. 
Two separate control analyses were conducted. In one analysis we used our 
matched surgical controls. The average age in both hypothyroid subjects and 
controls was 61.1 years. In the other analysis, each hypothyroid patient’s own 
personal health information was entered into the American College of Surgeons 
National Surgical Quality Improvement Program (ACS NSQIP) surgical risk 
calculator [13] and the predicted length of stay from the calculator was com-
pared against the actual length of stay. This calculator has been validated in mul-
tiple studies [14] [15] [16]. Its data is based on over 1.4 million patients cared for  
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Table 1. Characteristics of the cohort of patients (N = 29) and controls (N = 29). Statis-
tical comparison between patients and controls by sex and age was performed by stu-
dent’s t-test and for ASA class by chi-square analysis. P values > 0.05 are considered 
non-significant (NS). NA = not applicable. 
Parameter Patients Controls P value 
Sex    
Male 15 15 NS 
Female 14 14 NS 
Mean Age ± SD (years) 61.1 ± 12.7 61.1 ± 11.7 NS 
ASA Class    
Class 2 2 3 NS 
Class 3 17 19 NS 
Class 4 10 7 NS 
Mean TSH ± SD (0.4 - 4.2 mcU/mL) 29.19 ± 20.54 NA  
Free T4  NA  
0.2 2   
0.3 1   
0.4 2   
0.5 5   
 
Table 2. Types of surgical procedures performed on hypothyroid patients. The number of 
patients treated by surgical procedure is listed. There were an equal number of control 
patients for each surgical procedure listed. 
Procedure Type Number of Patients (%) 
Laporatomy and/or Bowel Resection 6 (21) 
Pharygeolaryngectomy, Esophagoectomy/Plasty 5 (17) 
Wound or Bone Debridement 5 (17) 
Open Reduction/Internal Fixation Fracture 3 (10) 
Thoracic Corpectomy or Laminectomy 2 (7) 
Hip Arthorplasty 2 (7) 
LVAD Implantation and Sternotomy 1 (3) 
Cystectomy with Pouch Creation 1 (3) 
Nissen Fundoplication 1 (3) 
Femoral Artery Ligation 1 (3) 
Drainage of Subdural Hematoma 1 (3) 
Hernia Repair 1 (3) 
 
in 393 ACS NSQIP hospitals and encompasses 1557 unique CPT codes. Regres-
sion models were used to predict outcomes based on twenty-one preoperative 
risk factors achieving a Brier score of 0.011 for mortality and 0.069 for morbidity. 
2.2. Analysis of Data 
Every chart was reviewed by the authors to ensure data validity. Data points 
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were collected on all cases and controls, including demographics (age, gender, 
surgery location); surgical variables (surgical procedure, date, urgency, wound 
class, duration of surgery, time to extubation, and estimated blood loss); patient 
variables (ASA Class, functional status, creatinine, dialysis, obstructive sleep ap-
nea, chronic obstructive pulmonary disease, diabetes mellitus, congestive heart 
failure, coronary artery disease, previous cardiac event, hypertension, dissemi-
nated cancer, supplemental oxygen, chronic steroids, beta-blockers, calcium 
channel blockers, dyspnea, height, weight, smoking, sepsis, ascites, ventilator, 
and revised risk criteria); thyroid variables (TSH, free T4, thyroid hormone re-
placement, clinical assessment); and all primary and secondary outcomes. 
Length of stay was determined by the hospital day number at discharge regard-
less of the hour the patient was released. For example, if the patient was dis-
charged on hospital day three in the morning, a length of stay of three days was 
ascribed. Hypothermia was defined as temperature < 35˚C (<95˚F); bradycardia 
as a heart rate < 60 bpm; hypotension as systolic blood pressure < 90 mmHg, di-
astolic blood pressure < 60 mmHg, or mean arterial pressure < 70 mmHg intra-
operatively to 48 hours post-op. 
2.3. Statistics 
Statistical evaluation was made using the computer program R [17]. Specific 
modules and functions in that program used are given in quotes. Data were 
analyzed both parametrically with a t-test (“t.test” function) and confirmed 
non-parametrically with the Mann-Whitney test (“wilcox.test” function). The 
t-test used the Welch method which does not require the variances between 
groups to be equal. Where appropriate, paired t-tests were performed but results 
were no different from unpaired t-tests. Power calculations were made using the 
“power.t.test” function. Graphics were generated from the R program (using the 
“boxplot” function and the add-in module “ggplot2”). Linear regression analysis 
was also performed when appropriate (with the “lm” function). Categorical data 
were compared by chi-square analysis with Yates correction where applicable. 
3. Results 
3.1. Anesthetic Considerations 
All of the case subjects’ surgeries were performed under general anesthesia. Of 
the controls, two were done with MAC (monitored anesthesia care) and one 
under deep sedation. The remainder of the controls was performed under gener-
al anesthesia. The anesthetic agents most commonly used in the hypothyroid 
group were propofol (twenty-five of twenty-nine), fentanyl (twenty of twen-
ty-nine), and midazolam (nineteen of twenty-nine). Etomidate and ketamine 
were used in a minority of patients (four and three patients, respectively). The 
most frequent neuromuscular blocker utilized in the hypothyroid group was ro-
curonium (nineteen of twenty-nine). Other agents used were succinylcholine, 
cisatracurium, pancuronium, and vecuronium. Similar rates of use were observed 
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in the control group.  
3.2. Primary Outcomes 
We initially compared the predicted length of stay from the NSQIP risk calcula-
tor to the actual length of stay from the twenty-nine patients. We found that the 
hypothyroid patients had a statistically significant longer length of stay than 
predicted, which at 14.4 days was more than twice that of the predicted value of 
6.9 days (Figure 1(a)). In order to be sure that this average length of stay was 
not skewed by a few patients that may have had a prolonged stay, we also looked 
at the number of patients whose length of stay was longer than that predicted. 
We found that twenty-one of the twenty-nine subjects had a statistically signifi-
cantly (P < 0.001) longer than predicted length of stay (Figure 1(b)). 
Because the much longer length of stay surprised us, we wanted to make sure 
this was not due to a system wide difference in patient management in our hos-
pitals compared to others. Therefore, we obtained a matched set of controls 
from our electronic medical record of patients who were not hypothyroid with 
the same surgical procedure and similar comorbidities. We then compared their 
length of stay with that calculated from the NSQIP risk calculator. These control 
patients had an actual length of stay of 9.6 days that was not significantly differ-
ent from the predicted 7.1 days (Figure 1(a)). Moreover, the average length of  
 
 
Figure 1. (a): Predicted and actual length of stay. Box plots of the actual length of stay 
and the NSQIP predicted length of stay. Each box shows the median and interquartile 
range for the listed group. The whiskers show the range. The dots indicate values that are 
more than 1.5 times greater than the interquartile range. The mean length of stay in the 
Patients group is 14.4 and 6.7 days for the Actual and Predicted, respectively. The mean 
length of stay in the Controls group is 9.1 and 7.1 days for the Actual and Predicted, re-
spectively. The P values shown were determined by the 2-samplettest and were confirmed 
by the Wilcoxan rank sum test. (b): Differences between actual and predicted length of 
Stay. The box plots show the median and interquartile ranges of the actual differences 
between each patient’s length of stay and that predicted by the NSQIP calculator. The 
whiskers show the range of values and the dots are plotted for those values when they ex-
ceed 1.5 times the interquartile range. The mean difference is 7.8 days for the patients and 
2.1 days for the Controls. The P value was determined by the 2-sample t test and con-
firmed by the Wilcoxan rank sum test. 
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stay of the controls was significantly less than that of the hypothyroid patients 
(P = 0.05). This difference is readily appreciated in Figure 1(b) showing that the 
mean length of stay was 7 days longer than predicted in the hypothyroid patients 
and only 2 days longer than predicted in the controls. This difference was also 
statistically significant (P = 0.02). 
Since the hypothyroid patients had a significantly longer length of stay com-
pared with the predicted length of stay, we also looked at the relationship be-
tween the length of stay and the serum TSH. We found no significant relation-
ship between the actual length of stay or the increase in the length of stay, and 
the TSH or the logarithm of TSH. 
We also looked at the other primary outcomes. One patient in the hypothyro-
id group died compared to none in the control group. Two patients in the hy-
pothyroid group experienced atrial fibrillation. One patient in each group had 
pulseless electrical activity arrest. The number of these complications was too 
small to determine if they were different between the groups. 
3.3. Secondary Outcomes 
While five of the patients had postoperative hypothermia compared to none of 
the controls, the P-value for this difference was 0.06. Even though there was no 
significant difference found between either group in the other outcomes (Figure 
2), in the hypothyroid group there was a trend toward higher incidence of ileus,  
 
 
Figure 2. Secondary outcomes. Secondary outcomes are plotted 
against the number of occurrences of each event. There were 29 
subjects in each group. The 4 patients with hypothermia were sig-
nificantly different from the 0 Controls (P = 0.03) by chi-square 
test, but there were no significant differences within the other 
events. There were 0 control subjects in both the Hypothermia and 
Reintubation events. AMS = altered mental status. 
R. Villavicencio, C. N. Mariash 
 
 
DOI: 10.4236/ijcm.2019.1012053 646 International Journal of Clinical Medicine 
 
use of vasopressors, and need for reintubation despite approximately equal rates 
of chronic obstructive pulmonary disease amongst both groups (38% compared 
to 41%) and a lower incidence of obstructive sleep apena amongst the hypothy-
roid group (7% compared to 14%). We also found that four hypothyroid patients 
failed to mount a fever when infected. Additionally, the magnitude of hypoten-
sion was slightly more pronounced in the hypothyroid group with an average 
low mean arterial pressure of 51 mmHg vs 56 mmHg in the controls. Approx-
imately equivalent rates of bradycardia were observed (45% in the hypothyroid 
group vs 41% in the controls) even though hypothyroid patients were less than 
half as likely to be taking a calcium channel blocker or beta-blocker (31% vs 
75%). 
4. Discussion 
Our study was prompted by reports that surgical outcomes may be improved 
with pre-operative assessment of patient comorbidities (see, for example [18]). 
However, these reports generally do not provide advice on how to handle pa-
tients found to be hypothyroid. Currently routine testing for hypothyroidism is 
not recommended as part of the pre-operative assessment. However, if a new 
diagnosis of hypothyroidism is discovered, delay of surgery has been recom-
mended in patients with “overt symptoms, significant clinical findings of hypo-
thyroidism, or very low thyroid hormone levels” [19]. However, precise thre-
sholds of what constitutes very low thyroid hormone levels or “significant” clin-
ical symptoms have not been established. Neither has it been established on how 
to best weigh these risks against the urgency of the surgery under consideration. 
Thus, the assessing physician is often left in a quandary as to whether to recom-
mend postponement of surgery while waiting for treatment of the hypothyroid-
ism. The majority of the hypothyroid patients in our study had thyroid testing 
done either on the day of surgery (eight of twenty-nine) or prior to surgery 
(twelve of twenty-nine). Possibly, because most of the procedures were necessary 
or urgent in nature, the evaluating physician may have felt the benefit of pro-
ceeding with surgery outweighed the risk. Several patients (nine of twenty-nine) 
had their thyroid function tests drawn within a few days after surgery (all but 
one within one to five days of surgery with the longest interval in one patient of 
ten days post) and so were not evaluated preoperatively. We speculate that be-
cause several of the patients had a known history of hypothyroidism and had 
been prescribed thyroid medication, the attending physician assumed these pa-
tients were adequately replaced. Nevertheless, presuming this assumption were 
correct, we felt it was important to entertain the possibility that post-op changes 
in nutrition, medications, or management, may have altered the thyroid func-
tion test results. Therefore, a subanalysis was conducted excluding the 9 subjects 
who had only post-op thyroid function tests. However, similar primary outcome 
findings persisted with the average length of stay of the remaining 20 hypothy-
roid patients being 14.0 days compared to the predicted value of 6.9 days.  
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Earlier literature does provide evidence of increased risk when operating on 
patients with significant hypothyroidism [20]. Moreover, there is the suggestion 
that hypothyroid subjects operated upon for spine surgery may have a 1-day in-
crease in length of stay that was even much longer if the patient had poorly con-
trolled diabetes mellitus [21]. This finding stands in contrast with that of Syed 
and co-workers who found that there was no significant outcome difference in 
patients with elevated TSH on thyroid supplement who underwent coronary 
bypass surgery [22] and to Sherman et al. who found no effect on outcomes in 
hypothyroid patients undergoing angioplasty [23]. More recent data add further 
confusion to the outcome of surgery on hypothyroid patients. 
One can speculate that the increased length of stay may be related to the se-
verity of hypothyroidism. However, it is important to emphasize the prolonged 
length of stay of our patients was not correlated with the TSH value. Thus, the 
increased morbidity noted in this study is not related to the degree of hypothy-
roidism, in as much as the TSH is an indicator of the degree of hypothyroidism. 
Rather, it suggests it is related to the presence versus absence of hypothyroidism 
per se. This observation suggests that consideration of postponing surgery to 
correct hypothyroidism should be given to all hypothyroid patients. Komatsu et 
al. found no association of hypothyroidism with length of stay or other compli-
cations in patients undergoing cardiac surgery [24]. However, other papers have 
reported significant increase in complications for valve replacement [25] or 
higher mortality in hypothyroid subjects with soft-tissue infections [26]. 
We recognize that there are several potential weaknesses with our study. The 
study was retrospective in nature and the number of subjects we studied was rel-
atively small. However, there are a number of strengths of our study as well. We 
carefully reviewed the charts of all the study and control subjects to assure the 
data and conclusions were accurate. We also did not limit the type of surgery to 
one specialty or even to one hospital within our network. Thus, our findings are 
generalizable. Our observations indicate that, in contrast to our initial hypothe-
sis, hypothyroidism is associated with markedly increased length of hospital stay. 
However, despite a trend toward increased risk of several secondary outcomes, 
the absolute incidence of these did not significantly differ. This study was not 
sufficiently powered to discern differences in mortality or post-operative cardiac 
complications. It does indicate however that, even with modern techniques and 
anesthesia, there remains a significantly increased risk of operating on a hypo-
thyroid patient. We believe this would be manifested by increased burden on the 
patient both monetarily and through consequences to their health as well as in 
the cost to the institution in facility fees and manpower. While hypothyroidism 
may not be an absolute contraindication to necessary procedures, we suggest 
that length of stay in such patients may be prolonged by 50%. Therefore, elective 
surgeries should be delayed until the patient is euthyroid. Whether pre-operative 
assessment should include a measurement of TSH will require a larger study to 
assess the overall risks and benefits to hypothyroid patients. It would also be 
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valuable to compare hypothyroid patients whose surgery was postponed to achieve 
euthyroid status with those whose surgery was not postponed. 
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